NDAORALTABLET, EXTENDED RELEASE
Approved
Jun 1994
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
3/8 — Basic
TYLENOL (acetaminophen) by Gland Pharma is 12. First approved in 1994.
Drug data last refreshed 8h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Tylenol (acetaminophen) is an oral analgesic and antipyretic small molecule used to treat pain and fever across multiple indications. The precise mechanism is not fully established but is thought to involve central nervous system actions. It does not affect platelet aggregation or hemostasis, making it distinct from NSAIDs.
LOE Approaching
Product is approaching loss of exclusivity with high generic competition (30% competitive pressure), signaling shrinking brand team and transitional career dynamics.
Mechanism of Action
12.1 Mechanism of Action The precise mechanism of the analgesic and antipyretic properties of acetaminophen is not established but is thought to primarily involve central actions. 12.2 Pharmacodynamics Acetaminophen has been shown to have analgesic and antipyretic activities in animal and human…
Worked on TYLENOL at Gland Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.